AAAAAA
Results: 76-100/282
Authors:
KEEVERTAYLOR CA
WITT PL
TRUITT RL
RAMANUJAM S
BORDEN EC
RITCH PS
Citation: Ca. Keevertaylor et al., HEMATOLOGIC AND IMMUNOLOGICAL EVALUATION OF RECOMBINANT HUMAN INTERLEUKIN-6 IN PATIENTS WITH ADVANCED MALIGNANT DISEASE - EVIDENCE FOR MONOCYTE ACTIVATION, Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 231-243
Authors:
NEVILLE DM
SCHARFF J
HU HZ
RIGAUT K
SHILOACH J
SLINGERLAND W
JONKER M
Citation: Dm. Neville et al., A NEW REAGENT FOR THE INDUCTION OF T-CELL DEPLETION, ANTI-CD3-CRM9, Journal of immunotherapy with emphasis on tumor immunology, 19(2), 1996, pp. 85-92
Authors:
FUNAKOSHI S
LONGO DL
MURPHY WJ
Citation: S. Funakoshi et al., DIFFERENTIAL IN-VITRO AND IN-VIVO ANTITUMOR EFFECTS MEDIATED BY ANTI-CD40 AND ANTI-CD20 MONOCLONAL-ANTIBODIES AGAINST HUMAN B-CELL LYMPHOMAS, Journal of immunotherapy with emphasis on tumor immunology, 19(2), 1996, pp. 93-101
Authors:
MESCHER MF
ROGERS JD
Citation: Mf. Mescher et Jd. Rogers, IMMUNOTHERAPY OF ESTABLISHED MURINE TUMORS WITH LARGE MULTIVALENT IMMUNOGEN AND CYCLOPHOSPHAMIDE, Journal of immunotherapy with emphasis on tumor immunology, 19(2), 1996, pp. 102-112
Authors:
BAUSERO MA
PANOSKALTSISMORTARI A
BLAZAR BR
KATSANIS E
Citation: Ma. Bausero et al., EFFECTIVE IMMUNIZATION AGAINST NEUROBLASTOMA USING DOUBLE-TRANSDUCED TUMOR-CELLS SECRETING GM-CSF INTERFERON-GAMMA, Journal of immunotherapy with emphasis on tumor immunology, 19(2), 1996, pp. 113-124
Authors:
DESTEFANI A
VALENTE G
FORNI G
LERDA W
RAGONA R
CORTESINA G
Citation: A. Destefani et al., TREATMENT OF ORAL CAVITY AND OROPHARYNX SQUAMOUS-CELL CARCINOMA WITH PERILYMPHATIC INTERLEUKIN-2 - CLINICAL AND PATHOLOGICAL CORRELATIONS, Journal of immunotherapy with emphasis on tumor immunology, 19(2), 1996, pp. 125-133
Authors:
CITTERIO G
FRAGASSO G
ROSSETTI E
DILUCCA G
BUCCI E
FOPPOLI M
GUERRIERI R
MATTEUCCI P
POLASTRI D
SCAGLIETTI U
TRESOLDI M
CHIERCHIA SL
RUGARLI C
Citation: G. Citterio et al., ISOLATED LEFT-VENTRICULAR FILLING ABNORMALITIES MAY PREDICT INTERLEUKIN-2-INDUCED CARDIOVASCULAR TOXICITY, Journal of immunotherapy with emphasis on tumor immunology, 19(2), 1996, pp. 134-141
Authors:
CURTI BD
URBA WJ
LONGO DL
JANIK JE
SHARFMAN WH
MILLER LL
CIZZA G
SHIMIZU M
OPPENHEIM JJ
ALVORD WG
SMITH JW
Citation: Bd. Curti et al., ENDOCRINE EFFECTS OF IL-1-ALPHA AND IL-1-BETA ADMINISTERED IN A PHASE-I TRIAL TO PATIENTS WITH ADVANCED CANCER, Journal of immunotherapy with emphasis on tumor immunology, 19(2), 1996, pp. 142-148
Authors:
BELLDEGRUN A
TSO CL
KABOO R
PANG S
PIERCE W
DEKERNION JB
FIGLIN R
Citation: A. Belldegrun et al., NATURAL IMMUNE REACTIVITY-ASSOCIATED THERAPEUTIC RESPONSE IN PATIENTSWITH METASTATIC RENAL-CELL CARCINOMA RECEIVING TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2-BASED THERAPY, Journal of immunotherapy with emphasis on tumor immunology, 19(2), 1996, pp. 149-161
Authors:
BEUN GDM
VLASVELD LT
BOT F
GRATAMA JW
SLINGERLAND R
VANTVEER MB
Citation: Gdm. Beun et al., LOW-DOSE RIL-2-INDUCED REMISSION OF DISSEMINATED CD30(-CELL LYMPHOMA THROUGH REINFORCEMENT OF PRESUMED T-CELL-MEDIATED TUMOR-CELL KILLING, COMPLICATED BY UNILATERAL DROWNING OF LYMPHOMA-INFILTRATED LUNG() ANAPLASTIC LARGE), Journal of immunotherapy with emphasis on tumor immunology, 19(2), 1996, pp. 162-167
Authors:
WANG YC
ZHU LH
MCHUGH R
GRAHAM SD
HILLYER CD
DILLEHAY D
SELL KW
SELVARAJ P
Citation: Yc. Wang et al., INDUCTION OF AUTOLOGOUS TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTE ACTIVITY AGAINST A HUMAN RENAL-CARCINOMA CELL-LINE BY B7-1 (CD80) COSTIMULATION, Journal of immunotherapy with emphasis on tumor immunology, 19(1), 1996, pp. 1-8
Authors:
WANG G
KLOSTERGAARD J
KHODADADIAN M
WU J
WU TW
FUNG KP
CARPER SW
TOMASOVIC SP
Citation: G. Wang et al., MURINE CELLS TRANSFECTED WITH HUMAN HSP27 CDNA RESIST TNF-INDUCED CYTOTOXICITY, Journal of immunotherapy with emphasis on tumor immunology, 19(1), 1996, pp. 9-20
Authors:
STROME SE
CHANG AE
SHU SY
KRAUSS JC
Citation: Se. Strome et al., SECRETION OF BOTH IL-2 AND IL-4 BY TUMOR-CELLS RESULTS IN REJECTION AND IMMUNITY, Journal of immunotherapy with emphasis on tumor immunology, 19(1), 1996, pp. 21-32
Authors:
NOOIJEN PTGA
EGGERMONT AMM
VERBEEK MM
SCHALKWIJK L
BUURMAN WA
DEWAAL RMW
RUITER DJ
Citation: Ptga. Nooijen et al., TRANSIENT INDUCTION OF E-SELECTIN EXPRESSION FOLLOWING TNF-ALPHA-BASED ISOLATED LIMB PERFUSION IN MELANOMA AND SARCOMA PATIENTS IS NOT TUMOR-SPECIFIC, Journal of immunotherapy with emphasis on tumor immunology, 19(1), 1996, pp. 33-44
Authors:
NURNBERGER W
HOLTHAUSEN S
MICHELMANN I
JURGENS H
BURDACH S
GOBEL U
Citation: W. Nurnberger et al., GENERATION OF THE COMPLEMENT ACTIVATION PRODUCT C5A PRECEDES INTERLEUKIN-2-INDUCED CAPILLARY LEAKAGE SYNDROME, Journal of immunotherapy with emphasis on tumor immunology, 19(1), 1996, pp. 45-49
COMBINATION THERAPY WITH INTERFERON-GAMMA AND INTERLEUKIN-2 FOR THE TREATMENT OF METASTATIC MELANOMA
Authors:
KIM CJ
TAUBENBERGER JK
SIMONIS TB
WHITE DE
ROSENBERG SA
MARINCOLA FM
Citation: Cj. Kim et al., COMBINATION THERAPY WITH INTERFERON-GAMMA AND INTERLEUKIN-2 FOR THE TREATMENT OF METASTATIC MELANOMA, Journal of immunotherapy with emphasis on tumor immunology, 19(1), 1996, pp. 50-58
Authors:
MACLEAN GD
REDDISH MA
KOGANTY RR
LONGENECKER BM
Citation: Gd. Maclean et al., ANTIBODIES AGAINST MUCIN-ASSOCIATED SIALYL-TN EPITOPES CORRELATE WITHSURVIVAL OF METASTATIC ADENOCARCINOMA PATIENTS UNDERGOING ACTIVE SPECIFIC IMMUNOTHERAPY WITH SYNTHETIC STN VACCINE, Journal of immunotherapy with emphasis on tumor immunology, 19(1), 1996, pp. 59-68
Authors:
OLENCKI T
FINKE J
TUBBS R
TUASON L
GREENE T
MCLAIN D
SWANSON SJ
HERZOG P
STANLEY T
EDINGER M
BUDD GT
BUKOWSKI RM
Citation: T. Olencki et al., IMMUNOMODULATORY EFFECTS OF INTERLEUKIN-2 AND INTERLEUKIN-4 IN PATIENTS WITH MALIGNANCY, Journal of immunotherapy with emphasis on tumor immunology, 19(1), 1996, pp. 69-80
Authors:
ROSENBERG SA
WHITE DE
Citation: Sa. Rosenberg et De. White, VITILIGO IN PATIENTS WITH MELANOMA - NORMAL TISSUE ANTIGENS CAN BE TARGETS FOR CANCER-IMMUNOTHERAPY, Journal of immunotherapy with emphasis on tumor immunology, 19(1), 1996, pp. 81-84
Authors:
FISK B
SAVARY C
HUDSON JM
OBRIAN CA
MURRAY JL
WHARTON JT
IOANNIDES CG
Citation: B. Fisk et al., CHANGES IN AN HER-2 PEPTIDE UP-REGULATING HLA-A2 EXPRESSION AFFECT BOTH CONFORMATIONAL EPITOPES AND CTL RECOGNITION - IMPLICATIONS FOR OPTIMIZATION OF ANTIGEN PRESENTATION AND TUMOR-SPECIFIC CTL INDUCTION, Journal of immunotherapy with emphasis on tumor immunology, 18(4), 1995, pp. 197-209
Authors:
ORUCEVIC A
LALA PK
Citation: A. Orucevic et Pk. Lala, N-G-NITRO-L-ARGININE METHYL-ESTER, AN INHIBITOR OF NITRIC-OXIDE SYNTHESIS, AMELIORATES INTERLEUKIN-2-INDUCED CAPILLARY LEAK SYNDROME IN HEALTHY MICE, Journal of immunotherapy with emphasis on tumor immunology, 18(4), 1995, pp. 210-220
Authors:
OBOYLE KP
COLLETTI D
MAZUREK C
WANG Y
RAY SK
DIAMOND B
ROSENBLUM MG
EPSTEIN AL
SHOCHAT D
DUTCHER JP
WIERNIK PH
KLEIN RS
Citation: Kp. Oboyle et al., POTENTIATION OF ANTIPROLIFERATIVE EFFECTS OF MONOCLONAL-ANTIBODY LYM-1 AND IMMUNOCONJUGATE LYM-1-GELONIN ON HUMAN BURKITTS-LYMPHOMA CELLS WITH GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR, Journal of immunotherapy with emphasis on tumor immunology, 18(4), 1995, pp. 221-230
Authors:
CONRY RM
KHAZAELI MB
SALEH MN
GHETIE V
VITETTA ES
LIU TP
LOBUGLIO AF
Citation: Rm. Conry et al., PHASE-I TRIAL OF AN ANTI-CD19 DEGLYCOSYLATED RICIN-A CHAIN IMMUNOTOXIN IN NON-HODGKINS-LYMPHOMA - EFFECT OF AN INTENSIVE SCHEDULE OF ADMINISTRATION, Journal of immunotherapy with emphasis on tumor immunology, 18(4), 1995, pp. 231-241
Authors:
MARINCOLA FM
SHAMAMIAN P
RIVOLTINI L
SALGALLER M
CORMIER J
RESTIFO NP
SIMONIS TB
VENZON D
WHITE DE
PARKINSON DR
Citation: Fm. Marincola et al., HLA ASSOCIATIONS IN THE ANTITUMOR RESPONSE AGAINST MALIGNANT-MELANOMA, Journal of immunotherapy with emphasis on tumor immunology, 18(4), 1995, pp. 242-252
Authors:
CHANG AE
CAMERON MJ
SONDAK VK
GEIGER JD
VANDERWOUDE DL
Citation: Ae. Chang et al., A PHASE-II TRIAL OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN THE TREATMENT OF METASTATIC COLORECTAL-CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 18(4), 1995, pp. 253-262